Received Jul 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | OT |
lightheadedness; anxiety; This spontaneous report was received from a nurse on 24-Jul-2025, referring to a 11-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Jul-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), administered by intramuscular route (lot # and expiration date were not reported) as prophylaxis of human papillomavirus (HPV). On 24-Jul-2025, the patient experienced anxiety and lightheadedness. The reporter believed that vaccination caused anxiety and lightheadedness was due to anxiety. She made a full recovery after 20 minutes of incident. The patient recovered from the events on that day. It is unknown if patient received their full doses. The action taken with human papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) was reported as not applicable. The reporter considered the events to be related to Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9).